The fact that intratumoral cisplatin does not increase neither CD8+ nor CD4+ T cell infiltration and that the effect was abolished in NSG mice (lacking T cells but with reduced macrophage function) suggests that macrophages could be partially responsible for the anti-tumour effects. The gene discussed is CD8A; the disease is neoplasm.